The acid-labile subunit (ALS) of the 150 kDa IGF-binding protein complex: an important but forgotten component of the circulating IGF system

被引:192
作者
Boisclair, YR
Rhoads, RP
Ueki, I
Wang, J
Ooi, GT
机构
[1] Cornell Univ, Dept Anim Sci, Ithaca, NY 14853 USA
[2] Prince Henrys Inst Med Res, Clayton, Vic 3168, Australia
关键词
D O I
10.1677/joe.0.1700063
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The insulin-like growth factors-I and -II (IGFs) are involved in a wide array of cellular processes such as proliferation, prevention of apoptosis, and differentiation. Most of these effects are mediated by the IGF-I receptor, although at higher IGF concentrations the insulin receptor can also be activated. As the expression of both the IGFs and their receptors is widespread, IGFs are thought to have autocrine/paracrine modes of actions also, particularly during foetal life. The endocrine component of the IGF system is recognised to be important after birth, with IGF-I mediating many of the effects of growth hormone (GH), and linking anabolic processes to nutrient availability. Consideration of ligands and receptors, however, is insufficient to provide a complete understanding of the biology of IGF. This is because IGFs are found in binary complexes of 40-50 kDa with members of a family of IGF-binding proteins (IGFBPs-1 to -6) in all biological fluids. In addition, in postnatal serum, most IGFs are sequestered into ternary complexes of 150 kDa consisting of one molecule each of IGF, IGFBP-3 or IGFBP-5, and acid-labile subunit (ALS). Despite evidence that ALS plays an important role in the biology of circulating IGFs, it has received only Limited attention relative to the other components of the IGF system. This review provides an overview on the current knowledge of ALS protein and gene structure, organisation and regulation by hormones, and insights from novel animal models such as the ALS knockout mice.
引用
收藏
页码:63 / 70
页数:8
相关论文
共 89 条
[31]   Imprinted genes in liver carcinogenesis [J].
deSouza, AT ;
Yamada, T ;
Mills, JJ ;
Jirtle, RL .
FASEB JOURNAL, 1997, 11 (01) :60-67
[32]   Biology of somatotropin in growth and lactation of domestic animals [J].
Etherton, TD ;
Bauman, DE .
PHYSIOLOGICAL REVIEWS, 1998, 78 (03) :745-761
[33]   Structural determinants of ligand and cell surface binding of insulin-like growth factor-binding protein-3 [J].
Firth, SM ;
Ganeshprasad, U ;
Baxter, RC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (05) :2631-2638
[34]   Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells [J].
Frasca, F ;
Pandini, C ;
Scalia, P ;
Sciacca, L ;
Mineo, R ;
Costantino, A ;
Goldfine, ID ;
Belfiore, A ;
Vigneri, R .
MOLECULAR AND CELLULAR BIOLOGY, 1999, 19 (05) :3278-3288
[35]  
Frost R A, 1998, Curr Opin Clin Nutr Metab Care, V1, P195, DOI 10.1097/00075197-199803000-00010
[36]   Developmental changes in serum levels of free and total insulin-like growth factor I (IGF-I), IGF-Binding protein-1 and -3, and the acid-labile subunit in rats [J].
Frystyk, J ;
Gronbæk, H ;
Skjærbæk, C ;
Flyvbjerg, A ;
Orskov, H ;
Baxter, RC .
ENDOCRINOLOGY, 1998, 139 (10) :4286-4292
[37]   Decreased serum levels of acid-labile subunit in patients with anorexia nervosa [J].
Fukuda, I ;
Hotta, M ;
Hizuka, N ;
Takano, K ;
Ishikawa, Y ;
Asakawa-Yasumoto, K ;
Tagami, E ;
Demura, H .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (06) :2034-2036
[38]   ADMINISTRATION OF GROWTH-HORMONE (GH), BUT NOT INSULIN-LIKE GROWTH-FACTOR-I (IGF-I), BY CONTINUOUS-INFUSION CAN INDUCE THE FORMATION OF THE 150-KILODALTON IGF-BINDING PROTEIN-3 COMPLEX IN GH-DEFICIENT RATS [J].
GARGOSKY, SE ;
TAPANAINEN, P ;
ROSENFELD, RG .
ENDOCRINOLOGY, 1994, 134 (05) :2267-2276
[39]   THE ONTOGENY OF SOMATOTROPIC BINDING-SITES IN OVINE HEPATIC MEMBRANES [J].
GLUCKMAN, PD ;
BUTLER, JH ;
ELLIOTT, TB .
ENDOCRINOLOGY, 1983, 112 (05) :1607-1612
[40]   INSULIN-LIKE GROWTH FACTOR-I AND FACTOR-II IN HEALTHY MAN - ESTIMATIONS OF HALF-LIVES AND PRODUCTION-RATES [J].
GULER, HP ;
ZAPF, J ;
SCHMID, C ;
FROESCH, ER .
ACTA ENDOCRINOLOGICA, 1989, 121 (06) :753-758